Matthew Rousculp
Vice President of Novavax.
Articles
Novavax COVID-19 Vaccine Linked to Fewer Adverse Effects in Health Care Workers and First Responders
April 28th 2025At ESCMID Global 2025, SHIELD study data show Novavax recipients experienced fewer adverse effects and missed less work compared with those who received the Pfizer-BioNTech COVID-19 vaccine.
Read More
Latest Updated Articles
Published: August 27th 2024 | Updated: August 28th 2024
Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
Published: May 20th 2025 | Updated: May 23rd 2025
Computational Model Maps Over 67,000 Malaria Epitopes to Improve Vaccine Targeting
Published: May 19th 2025 | Updated: May 23rd 2025
With Its Global Bacterial Meningitis Guidelines, WHO Aims to Speed Up Diagnosis, Treatment
Published: May 20th 2025 | Updated: May 23rd 2025
Ceftobiprole Launches Commercially in US
Published: May 14th 2025 | Updated: May 23rd 2025
New Report Calls For Funding Treatments, Greater Emphasis on Chronic Lyme Disease
Published: May 16th 2025 | Updated: May 23rd 2025
High Vaccine Acceptance in Sierra Leone Highlights Role of Trust, Messaging, and Misinformation
